Hazardous Drug Sample Analysis HT942726QE008
Summary
AI-generated · Apr 17, 2026Perform analysis of wipe/swab samples provided by the government to detect contamination with hazardous drugs at pharmacies and Military Treatment Facilities, to verify cleaning procedures and prevent cross-contamination. This work follows USP 800 and TB-MED 515 guidance, acknowledges that there is no acceptable occupational exposure level for hazardous drugs, and requires a backup laboratory capability since the current single government lab performs these analyses.
Contractor responsibilities include conducting the required analyses using an accredited methodology for various hazardous drugs, delivering results within the turnaround time stated in the Outsource Document and the PWS, and disposing of unused samples per the contractor’s quality manual/SOP while returning government shipping containers. They must supply sampling media upon request and accept liquidated damages for late or deficient reporting as described in Section 5 of the PWS. Questions and quotations deadlines apply per the PWS.
As part of the DCPH-A mission, the Lab Sciences (LS) Directorate requires the analysis of wipe/swab samples for the presence of hazardous drugs in support of pharmacies and Military Treatment Facilities (MTFs) within the Department of War (DoW). This analysis is mandated for the MTFs using Chemotherapy drugs to ensure their cleaning procedures are effective to ensure safety of the MTF staff and to avoid cross-contamination. The directives that mandate this semi-annual testing requirement are United Stated Pharmacopiea (USP) 800: Handling Hazardous Drugs and Technical Bulletin-Medical (TB-MED) 515: Occupational Health and Indutrial Hygiene Guidance for the Management, Use and Disposal of Hazardous Drugs. There is no acceptable level of occupational exposure to Hazardous Drugs. The LS Directorate of the DCPH-A is the only government laboratory to perform this hazardous drugs analysis as required. While LS does have the analytical capability to perform hazardous drugs analyses, as a sole source for this effort, there is a need to have back-up laboratory capability for instances of instrument down-time or over-capacity situations. Objectives for this Requirement are as follows: The Contractor shall perform analysis on wipe/swab samples provided by the Government for Hazardous Drugs contamination. The Contractor shall perform the sample analysis within the stated turnaround time (TAT) identified in the Outsource Document and identified in the PWS. The Contractor shall provide Quality wipe/swab analysis for various hazardous drugs as identified in this PWS in accordance with an accredited methodology. The Contractor shall dispose of unused samples as prescribed by their quality manual/Standing Operating Procedures and return Government shipping containers. The Contractor shall supply sampling media upon request. The Contractor shall pay liquidated damages for late or deficient reporting as detailed in Section 5.of the PWS. QUESTIONS are due by 20 April 2026 by 1pm Eastern Standard Time (EST) QUOTATIONS are due by 24 April 2026 by 11am EST. See the Performance Work Statement (PWS) for complete information regarding this effort.
From Solicitation posted on Apr 16, 2026Notice history
1-
Solicitation LATEST Posted Apr 16, 2026
Details
Award Information
Not yet awarded
Contacts
Phone
Phone
Agency
Place of Performance
USA